Skip to main
HNGE
HNGE logo

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health Inc. is expected to experience substantial growth driven by improving yields, which accounted for approximately 25% of their annual growth in 2024 and are anticipated to continue increasing. Despite a current penetration rate of only 3.5% among eligible employees compared to the 9% rate of traditional physical therapy, the company's strategic tools, such as Hinge Connect, are designed to improve engagement and drive higher yields. Additionally, the company has demonstrated strong net revenue retention (NRR) rates of 116-117% over the past two years, suggesting robust customer loyalty and ongoing revenue growth potential.

Bears say

Hinge Health Inc's 2Q25 earnings report indicated an EBIT margin of 19%, yet management's guidance for mid-teens EBIT margins in the latter half of 2025 raises concerns about sustainable profitability moving forward. The projected consensus EBIT margins of 14.6% for FY26 and 16.2% for FY27 appear to be low, suggesting potential challenges in enhancing operational efficiency or managing costs. These outlook indicators may signal a troubling trajectory for the company's financial health and investor confidence.

HNGE has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 14 analysts, HNGE has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $57.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $57.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.